|
|
Volumn 9, Issue 4, 2017, Pages 320-324
|
|
American Diabetes Association Standards of Medical Care in Diabetes 2017
a a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIDIABETIC AGENT;
BIOLOGICAL MARKER;
BLOOD;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
HEALTH CARE QUALITY;
HEALTH SERVICE;
HUMAN;
INSULIN RESISTANCE;
METABOLISM;
MORTALITY;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORGANIZATION;
PRACTICE GUIDELINE;
STANDARDS;
TREATMENT OUTCOME;
UNITED STATES;
BIOMARKERS;
BLOOD GLUCOSE;
CONGRESSES AS TOPIC;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN RESISTANCE;
PRACTICE GUIDELINES AS TOPIC;
STANDARD OF CARE;
TREATMENT OUTCOME;
UNITED STATES;
VOLUNTARY HEALTH AGENCIES;
|
|
EID: 85063654764
PISSN: None
EISSN: 17530407
Source Type: Journal
DOI: 10.1111/1753-0407.12524 Document Type: Note |
|
Times cited : (370)
|
|
References (0)
|